Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
25.02
-0.50 (-1.96%)
Nov 16, 2026, 3:00 PM CST
SHA:603334 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 254.79 | 567.16 | 166.78 | 156.74 | 217.73 | 84.48 |
Trading Asset Securities | 450 | 300.14 | - | - | 0.83 | 0.18 |
Cash & Short-Term Investments | 704.79 | 867.3 | 166.78 | 156.74 | 218.57 | 84.66 |
Cash Growth | 564.72% | 420.01% | 6.40% | -28.29% | 158.18% | 118.62% |
Accounts Receivable | 317.25 | 249.2 | 244.82 | 157.4 | 181.05 | 164.82 |
Other Receivables | 17.1 | 33.98 | 17.46 | 18.59 | 12.21 | 7.45 |
Receivables | 334.35 | 283.17 | 262.29 | 175.99 | 193.26 | 172.27 |
Inventory | 512.06 | 522.6 | 242.01 | 198.38 | 104.24 | 118.48 |
Other Current Assets | 118.22 | 54.21 | 59.1 | 36.99 | 96.64 | 46.9 |
Total Current Assets | 1,669 | 1,727 | 730.18 | 568.1 | 612.7 | 422.31 |
Property, Plant & Equipment | 476.32 | 416.88 | 433.02 | 405.92 | 254.98 | 115.07 |
Goodwill | 14.76 | 0.02 | - | - | - | - |
Other Intangible Assets | 100.15 | 63.07 | 59.76 | 61.14 | 50.85 | 51.97 |
Long-Term Deferred Tax Assets | 11.77 | 11.66 | 8.86 | 4.71 | 6.06 | 4.21 |
Long-Term Deferred Charges | 1.35 | 1.62 | 2.61 | 3.91 | 4.63 | 3.66 |
Other Long-Term Assets | 3.84 | 4.82 | 2.33 | 7.66 | 8.61 | 1.87 |
Total Assets | 2,278 | 2,225 | 1,237 | 1,051 | 937.82 | 599.09 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 93.71 | 168.29 | 113.11 | 57.42 | 66.02 | 61.24 |
Accrued Expenses | 12.68 | 29.31 | 17.01 | 27.88 | 40.8 | 19.89 |
Short-Term Debt | 254.9 | 222.71 | 173.39 | 141.53 | 159.28 | 100.11 |
Current Portion of Long-Term Debt | 8.65 | 5.19 | 7.29 | 0.28 | 10.11 | - |
Current Portion of Leases | - | 0.95 | 3.08 | 3.37 | 5.02 | 0.33 |
Current Income Taxes Payable | 18.91 | 4.51 | 3.09 | 0.34 | 3.06 | 2.32 |
Current Unearned Revenue | 46.57 | 51.08 | 27.44 | 30.44 | 35.35 | 20.33 |
Other Current Liabilities | 26.27 | 9.77 | 14.12 | 75.38 | 53.51 | 9 |
Total Current Liabilities | 461.69 | 491.82 | 358.53 | 336.64 | 373.14 | 213.23 |
Long-Term Debt | - | 22.44 | 106.37 | 72.9 | 40.5 | - |
Long-Term Leases | 0.22 | 0.49 | 3.48 | - | 5.14 | - |
Long-Term Unearned Revenue | 16.67 | 10.48 | 11.36 | 11.91 | 2.03 | 2.55 |
Long-Term Deferred Tax Liabilities | 10.36 | 0.37 | 1.22 | 0.5 | 1.94 | 0.07 |
Other Long-Term Liabilities | 24.21 | - | - | - | 1.66 | 1 |
Total Liabilities | 513.14 | 525.6 | 480.96 | 421.95 | 424.41 | 216.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 143.5 | 143.5 | 107.6 | 107.6 | 107.6 | 105.79 |
Additional Paid-In Capital | 956.67 | 955.24 | 189.71 | - | - | 87.29 |
Retained Earnings | 659.32 | 599.04 | 458.48 | 521.9 | 405.82 | 187.69 |
Total Common Equity | 1,759 | 1,698 | 755.79 | 629.5 | 513.42 | 380.77 |
Minority Interest | 4.97 | 1.97 | - | - | - | 1.48 |
Shareholders' Equity | 1,764 | 1,700 | 755.79 | 629.5 | 513.42 | 382.25 |
Total Liabilities & Equity | 2,278 | 2,225 | 1,237 | 1,051 | 937.82 | 599.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 263.76 | 251.78 | 293.62 | 218.09 | 220.05 | 100.44 |
Net Cash (Debt) | 441.03 | 615.52 | -126.83 | -61.34 | -1.48 | -15.79 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 3.14 | 5.43 | -1.18 | -0.57 | -0.01 | -0.15 |
Filing Date Shares Outstanding | 143.5 | 143.5 | 107.6 | 143.5 | 107.6 | 106.16 |
Total Common Shares Outstanding | 143.5 | 143.5 | 107.6 | 143.5 | 107.6 | 106.16 |
Working Capital | 1,208 | 1,235 | 371.64 | 231.46 | 239.56 | 209.08 |
Book Value Per Share | 12.26 | 11.83 | 7.02 | 4.39 | 4.77 | 3.59 |
Tangible Book Value | 1,645 | 1,635 | 696.03 | 568.36 | 462.57 | 328.8 |
Tangible Book Value Per Share | 11.46 | 11.39 | 6.47 | 3.96 | 4.30 | 3.10 |
Buildings | - | 164.75 | 72.03 | 69.95 | 25.06 | 25.61 |
Machinery | - | 317.67 | 128.96 | 122.66 | 103.98 | 92.27 |
Construction In Progress | - | 25.2 | 291.81 | 262.7 | 155.85 | 27.76 |